Dare Bioscience Regains Nasdaq Compliance
Dare Bioscience (DARE) said Friday that it has regained compliance with Nasdaq's minimum bid price requirements.The biopharmaceutical company said its closing bid price remained at least $1 per
Express News | Daré Bioscience Regains Compliance With Nasdaq Minimum Bid Price Rule
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Dare Bioscience To Carry Out 1-for-12 Reverse Stock Split On July 1st, 2024
June 27th (Eastern Time) - $Dare Bioscience(DARE.US)$ is about to implement a 1-for-12 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from July 1st, 2024.$Dare
Express News | Dare Bioscience Shares Are Trading Lower After the Company Announced a 1-for-12 Reverse Stock Split
Express News | Dare Bioscience Inc - Implements 1-for-12 Reverse Stock Split
Dare Bioscience: Split Intended to Increase Bid Price of Common Stk to Enable Co to Regain Compliance With $1 Minimum Bid Price Requirement for Continued Listing on Nasdaq Cap Market >DARE
Dare Bioscience: Split Intended to Increase Bid Price of Common Stk to Enable Co to Regain Compliance With $1 Minimum Bid Price Requirement for Continued Listing on Nasdaq Cap Market >DARE
Express News | Daré Bioscience Announces Reverse Stock Split
Daré Bioscience Announces Publication Of Phase 2b Study Efficacy Results Of Topical Sildenafil Cream, 3.6% For The Treatment Of Female Sexual Arousal Disorder In Obstetrics & Gynecology
Phase 2b study demonstrated topical Sildenafil Cream, 3.6% improved outcomes among women with female sexual arousal disorder (FSAD), particularly in an exploratory subset of women with FSAD with or wi
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersCue Health (NASDAQ:HLTH) shares rose 70.1% to $0.09 during Thursday's regular session. The market value of their outstanding shares is at $14.8 million. OneMedNet (NASDAQ:ONMD) shares increased
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of James Hardie Industries plc (NYSE:JHX) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.James Hardie Industries posted adjuste
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) stock increased by 84.3% to $2.34 during Tuesday's regular session. The market value of their outstanding shares is at $10.2 million. Genelux (NASDAQ:GNLX)
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Bayer AG (OTC:BAYRY) (OTC:BAYZF) will present detailed results from the Phase 3 studies OASIS 1 and 2, showing that the investigational compound elinzanetant significantly reduced the frequency and se
Express News | Dare Bioscience Inc : Jonestrading Cuts Target Price to $5 From $6
Brookline Capital Upgrades Dare Bioscience, Cites Improved Funding
Q1 2024 Dare Bioscience Inc Earnings Call
Express News | Dare Bioscience Shares Are Trading Higher After Brookline Capital Upgraded the Stock From Hold to Buy and Announced a $3 Price Target
Express News | Brookline Capital Upgrades Dare Bioscience to Buy, Announces $3 Price Target
Earnings Call Summary | Dare Bioscience(DARE.US) Q1 2024 Earnings Conference
The following is a summary of the Daré Bioscience, Inc. (DARE) Q1 2024 Earnings Call Transcript:Financial Performance:Dare reported Q1 2024 general and administrative expenses of approximately $2.7 m
No Data